Management of Type 1 Supracondylar Humeral Fractures

Recruiting N/A Interventional Study
Elbow Fracture Trauma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 – 8
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
52 (estimated)
Sponsor
University of British Columbia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up. This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Children 3 to 8 years of age with a diagnosed supracondylar humerus fracture Type 1 (undisplaced). Exclusion Criteria: * Children diagnosed with a Type II or III supracondylar fracture or any other elbow injury * Children who present with neurovascular compromise associated…
Contacts

Harpreet Chhina, MSc

604-875-2000

hchhina@cw.bc.ca

CONTACT

Anthony Cooper, FRCSC

604-875-2000

externalfixators@cw.bc.ca

CONTACT